Terazosin - Compound Summary (CID 5401)
Also known as: Terazosine, Flumarc, Fosfomic, Vasomet, Blavin, Hytrin, Terazosine [INN-French], Terazosinum [INN-Latin], Terazosina [INN-Spanish]
Molecular Formula: C19H25N5O4   Molecular Weight: 387.4329   InChIKey: VCKUSRYTPJJLNI-UHFFFAOYSA-N
Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _